SCHEMBL24299331

SCHEMBL24299331

NCCCc1cc(F)ccc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 4/20 0.50
MEN1 O00255 2/20 0.45
RAD52 P43351 2/20 0.45
RECQL P46063 2/20 0.45
KMT2A Q03164 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
GAPDH P04406 1/20 0.45
THRB P10828 1/20 0.45
APEX1 P27695 1/20 0.45
BLM P54132 1/20 0.45
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
ALOX15 P16050 1/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
AGO2 Q9UKV8 1/20 0.44
CA3 P07451 1/20 0.43
CA6 P23280 1/20 0.43
CA5A P35218 1/20 0.43
CA9 Q16790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27587521 0.88 RECQL (0.59) MPOMEN1RAD52RECQLKMT2A
Hydrochloric Acid SCHEMBL21815105 0.86 RECQL (0.61) MPOMEN1RAD52RECQLKMT2A
SCHEMBL12520531 0.81 TYR (0.56) MPOMEN1KMT2ATDP1KDM4E
SCHEMBL633599 0.80 TYR (0.46) MEN1RAD52RECQLKMT2ATDP1
SCHEMBL620853 0.79 CA3 (0.44) MPOMEN1RAD52RECQLKMT2A
SCHEMBL1270868 0.79 ALOX5 (0.56) MEN1KMT2ATDP1KDM4EMAPT
SCHEMBL19174152 0.79 BCHE (0.42) MPOMEN1KMT2ATDP1MAPT
SCHEMBL5190794 0.78 PRKCI (0.52) MEN1RAD52RECQLKMT2ATDP1
SCHEMBL27571485 0.78 MPO (0.51) MPOKMT2AHTR2ATAAR1
Bromide SCHEMBL11674699 0.78 TYR (0.44) MEN1RAD52RECQLKMT2ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220117937-A1 USE OF SMALL MOLECULE INHIBITORS OF THE BFRB:BFD INTERACTION IN BIOFILMS BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220117937-A1 USE OF SMALL MOLECULE INHIBITORS OF THE BFRB:BFD INTERACTION IN BIOFILMS BLVRB, Q6ZSR9, BTD MPO 493/4885MEN1 4248/4885RAD52 2520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.